Serial #75307383
DEAD

Serial Number

75307383

Owner

TOYAMA CHEMICAL CO., LTD.

Attorney

Jeffrey H. Kaufman

First Use Date

Sep 21, 1999

Filing Date

Jun 11, 1997

Add to watchlist:

No watchlists yet
View on USPTO

Serial #75307383 Trademark

Serial Number: 75307383 • Registration: 2444646

Serial #75307383 is a trademark filed by TOYAMA CHEMICAL CO., LTD. on June 11, 1997. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

TOYAMA CHEMICAL CO., LTD. (9 trademarks)

No.2-5, Nishishinjuku 3-chome
Shinjuku-ku, Tokyo , JP

Entity Type: 03

Trademark Details

Filing Date

June 11, 1997

Registration Date

April 17, 2001

First Use Anywhere

September 21, 1999

First Use in Commerce

September 21, 1999

Published for Opposition

February 8, 2000

Cancellation Date

October 29, 2021

Goods & Services

medicines for human purposes, namely, pharmaceutical preparations for the treatment of the central nervous system, peripheral nervous system, sensory organs , [allergies, circulatory organs, respiratory organs, digestive organs, urogenital organs or anus, blood, tumors, physical disorders, chemical disorders, parasites; hormones; dermatological medicines; vitamins; dietary supplements in the nature of amino acids; food supplements; medicinal tonics to heal, cleanse, energize and strengthen the body; metabolic medicines;] antibiotics; [pharmaceutical preparations for use in the activation of cells and in chemotherapy; biological medicines, namely, vaccines, nutritional supplements for the stimulation of defensive mechanisms against toxins and toxoids and for the elimination of toxins and toxoids, antitoxins and anti-leptospira serums used for counteracting drugs or other toxic substances for use in poisionings and drug overdoses, and tetanus antitoxins, medical diagnostic reagents used in biological examination; pharmaceutical preparations for use in inducing narcosis; pharmaceutical preparations for use in diagnosis; namely, contrast media for radiography, reagents for function tests, general examination, hematological examination, blood chemistry examination, immuno-serological examination, bacteriological examination, histopathological examination, and radiopharmaceuticals for extrasomatic diagnosis ]

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Oct 29, 2021 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Apr 17, 2020 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2015 TCCA
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Apr 23, 2011 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 23, 2011 89AG
TEAS SECTION 8 & 9 RECEIVED
Apr 15, 2011 E89R
NOTICE OF DESIGN SEARCH CODE MAILED
Nov 21, 2008 MDSC
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 18, 2007 C15A
ASSIGNED TO PARALEGAL
Apr 10, 2007 PLGL
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Mar 13, 2007 815F
PAPER RECEIVED
Mar 13, 2007 MAIL
CASE FILE IN TICRS
Nov 15, 2006 CFIT
REGISTERED-PRINCIPAL REGISTER
Apr 17, 2001 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 5, 2001 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Dec 26, 2000 SUPC
SOU EXTENSION 1 GRANTED
Dec 19, 2000 EX1G
USE AMENDMENT FILED
Oct 3, 2000 IUAF
SOU EXTENSION 1 FILED
Oct 3, 2000 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 2, 2000 NOAM
PUBLISHED FOR OPPOSITION
Feb 8, 2000 PUBO
NOTICE OF PUBLICATION
Jan 7, 2000 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 1999 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 1999 CRFA
FINAL REFUSAL MAILED
Apr 20, 1999 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 1999 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 1999 CRFA
NON-FINAL ACTION MAILED
Aug 5, 1998 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 1998 CRFA
NON-FINAL ACTION MAILED
Dec 23, 1997 CNRT
ASSIGNED TO EXAMINER
Dec 22, 1997 DOCK